Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00244868 · ClinicalTrials.gov registry record · Phase 3

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

A Phase 3 study, sponsored by Fox Chase Cancer Center.

Completed
Registry status
Phase 3
Development phase
720
Enrollment target

NCT00244868 is a Phase 3 study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 720 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00244868, a Phase 3 study, has completed, sponsored by Fox Chase Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
720 participants
Enrollment target

Study Summary

RATIONALE: A computer-based survey and communication aid may help physicians and patients to communicate better and help make treatment decisions easier. PURPOSE: This phase III randomized clinical trial is studying how well giving a computer-based survey together with a communication aid works compared to a computer-based survey alone in improving physician-patient communication and treatment decision making in patients with metastatic cancer.

Interventions

  • OTHER educational intervention
  • OTHER counseling intervention

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2003-07
Phase Phase 3

Sponsor

Fox Chase Cancer Center

183 total trials

What the Registry Record Tells You About NCT00244868

The ClinicalTrials.gov registry entry for NCT00244868 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which educational intervention is the first listed.

NCT00244868 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00244868 about?

NCT00244868 is a clinical study titled "Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer". RATIONALE: A computer-based survey and communication aid may help physicians and patients to communicate better and help make treatment decisions easier. PURPOSE: This phase III randomized clinical trial is studying how well giving a computer-based survey together with a communication aid works com...

What is the current status of trial NCT00244868?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 720 participants. The study started on 2003-07.

What interventions are being tested in trial NCT00244868?

The interventions under investigation include: educational intervention (OTHER), counseling intervention (OTHER).

Who is sponsoring clinical trial NCT00244868?

This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.